State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,026,991 shares of common stock in Perspective Therapeutics Inc as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: State Street Corporation reported beneficial ownership of 2,026,991 shares of Perspective Therapeutics Inc common stock.
  • Percent of class: The reported holdings represent 1.8% of the outstanding class of common stock, according to the filing.
  • Shared voting power: State Street disclosed shared voting power over 1,922,605 shares, with sole voting power of 0.
  • Shared dispositive power: The filing shows shared dispositive power over 2,026,991 shares, with sole dispositive power of 0.
  • Triggering subsidiaries: The filing identifies three subsidiaries through which the position was held: SSGA Funds Management, Inc.; State Street Global Advisors Europe Limited; and State Street Global Advisors Trust Company, each classified as an investment adviser.
  • Event date: The date of the event requiring the filing was September 30, 2026.

State Street's Passive Holdings in Perspective Therapeutics as of September 30, 2026

State Street Corporation, a holding company organized in Massachusetts and headquartered at One Congress Street, Suite 1, Boston, MA 02114, filed a Schedule 13G disclosing a beneficial ownership position in Perspective Therapeutics Inc (CUSIP 46489V302). Perspective Therapeutics is headquartered at 2401 Elliott Ave Suite 320, Seattle, Washington 98121, according to the filing.

The filing reports aggregate beneficial ownership of 2,026,991 shares, representing 1.8% of the issuer's common stock class. State Street disclosed no sole voting or sole dispositive power over any of the shares. Shared voting power covers 1,922,605 shares, while shared dispositive power covers all 2,026,991 shares reported. The filing identifies the position as held through three subsidiaries: SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company, all classified as investment advisers (IA) in the filing.

State Street is identified in the filing as a parent holding company (Type: HC). The certification signed by Alok Maheshwary, Senior Vice President, states that "the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Item 5 of the filing confirms this represents ownership of 5 percent or less of the class. Item 6 notes the item is "NOT APPLICABLE," indicating no other person is identified as having the right to receive dividends or sale proceeds attributable to more than 5 percent of the class.

What Was Disclosed

State Street Corporation filed a Schedule 13G disclosing 2,026,991 shares, or 1.8%, of Perspective Therapeutics Inc common stock as of September 30, 2026, held through three investment adviser subsidiaries with shared but no sole voting or dispositive power.